- In Memoriam
- About
- Apply
- People
- Education
- Events
- Articles
-
News
News Fatty Liver Foundation Launches Groundbreaking Patient Advocacy Fellowship Honoring Dr. Stephen A. Harrison Fatty Liver Foundation Announces Inaugural Cohort of the Dr. Stephen A. Harrison Patient Advocacy Fellowship Fatty Liver Foundation to Introduce Dr. Stephen A. Harrison Patient Advocacy Fellowship at Liver Forum 19 in Paris, France The Dr. Stephen A. Harrison Patient Advocacy Fellowship Program on Surfing the MASH Tsunami
- FAQ
- Contact
Henry Chang Bio
Henry E. Chang, Executive Director
Henry E. Chang is a visionary leader with more than 30 years of experience in leading impact initiatives in global health, humanitarian assistance and disaster relief, public-private partnerships, corporate social responsibility, as well as patient advocacy and health policy development.
Prior to joining FLF, Henry worked in patient advocacy and non-profit organizations, government research agencies, life sciences industry, and boutique healthcare consulting companies in executive leadership and advisory positions, including the Global Business Coalition on HIV/AIDS, Tuberculosis, and Malaria, Doctors of the World/Médecins du Monde USA, AIDS Healthcare Foundation, the U.S. National Institute of Allergy and Infectious Diseases, DuPont Merck Pharmaceutical Company, and Health Business Solutions.
Henry is currently serving as a patient representative of the American Association for the Study of Liver Diseases (AASLD) Practice Guidelines Committee and a board member of Hep Free NYC and the Touch of Hope Foundation in India. Henry received his Bachelor of Science degree from the University of California, Los Angeles (UCLA), in biochemistry and molecular biology, and attended a PhD program at UCLA where he completed his clinical research fellowship in infectious diseases at Cedars-Sinai Medical Center.